Calton & Associates’s CryoPort CYRX Stock Holding History

Calton & Associates’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,000	Closed	-$8K	–	526
2017 Q4	$8K	Buy	+1,000	New	+$7.84K	﹤0.01%	1117

Other funds holding CYRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

TWMP

Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Calton & Associates's CYRX Position: Q1 2018 in Review

Calton & Associates sold out of CryoPort (CYRX) in Q1 2018, closing a stake of 1,000 shares — an estimated $8K sold.

Calton & Associates first reported a position in CYRX in Q4 2017 and held it in 1 quarter. The position peaked at $8K in Q4 2017. 68 funds tracked by Wall St. Rank hold CYRX as of Q1 2018.

Calton & Associates reported no remaining CryoPort position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 1,000 CryoPort shares in Q1 2018, an estimated $8K.
Calton & Associates first reported a position in CryoPort in Q4 2017 and held it in 1 quarter.
Calton & Associates's CryoPort position peaked at $8K in Q4 2017.
68 funds tracked by Wall St. Rank held CryoPort as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.